Horizon Europe ‘Health’ single-stage calls for proposals 2024

HaDEA has published a set of new calls under Cluster 1 ‘Health’ of Horizon Europe.

Under destination 3 “Tackling diseases and reducing disease burden” the calls address pandemic preparedness and response:

Under destination 5 “Unlocking the full potential of new tools, technologies and digital solutions for a healthy society” the call focuses on bio-printing of living cells for regenerative medicine:

Under destination 6 “Maintaining an innovative, sustainable and globally competitive health industry” the calls focus on fostering innovation in the health industry:

  • HORIZON-HLTH-2024-IND-06-08 – Developing EU methodological frameworks for clinical/performance evaluation and post-market clinical/performance follow-up of medical devices and in vitro diagnostic medical devices (IVDs)
  • HORIZON-HLTH-2024-IND-06-09 – Gaining experience and confidence in New Approach Methodologies (NAM) for regulatory safety and efficacy testing – coordinated training and experience exchange for regulators

The deadline to apply to these calls is on 11 April 2024, 17:00 CEST.

Another call under destination 3 will open in April 2024:


Horizon Europe is the research and innovation programme of the EU for the period 2021-2027.

The aims of Cluster 1 ‘Health’  include improving and protecting the health and well-being of citizens of all ages by generating new knowledge, developing innovative solutions and integrating where relevant a gender perspective to prevent, diagnose, monitor, treat and cure diseases. Horizon 2020 (H2020) was the EU’s multiannual funding programme between 2014 and 2020.

Source: European Commission | European Health and Digital Executive Agency (HaDEA) (https://shorturl.at/chkmz)